ReviewImmunologic research2024

NK/DC crosstalk-modulating antitumor activity via Sema3E/PlexinD1 axis for enhanced cancer immunotherapy.

Awais Ali et al.PubMed ↗Publisher ↗

No numbers read from the abstract.